[HTML][HTML] Challenges of advanced hepatocellular carcinoma
S Colagrande, AL Inghilesi, S Aburas… - World journal of …, 2016 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is an aggressive malignancy, resulting as the third cause
of death by cancer each year. The management of patients with HCC is complex, as both the …
of death by cancer each year. The management of patients with HCC is complex, as both the …
Assessment of liver tumor response to therapy: role of quantitative imaging
FD Gonzalez-Guindalini, MPF Botelho, CB Harmath… - Radiographics, 2013 - pubs.rsna.org
Quantitative imaging is the analysis of retrieved numeric data from images with the goal of
reducing subjective assessment. It is an increasingly important radiologic tool to assess …
reducing subjective assessment. It is an increasingly important radiologic tool to assess …
[HTML][HTML] Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives
R Sacco, V Mismas, S Marceglia… - World Journal of …, 2015 - ncbi.nlm.nih.gov
In the last decade trans-arterial radioembolization has given promising results in the
treatment of patients with intermediate or advanced stage hepatocellular carcinoma (HCC) …
treatment of patients with intermediate or advanced stage hepatocellular carcinoma (HCC) …
Validation of a fully automated liver segmentation algorithm using multi-scale deep reinforcement learning and comparison versus manual segmentation
Purpose To evaluate the performance of an artificial intelligence (AI) based software solution
tested on liver volumetric analyses and to compare the results to the manual contour …
tested on liver volumetric analyses and to compare the results to the manual contour …
Tumor dose response in yttrium-90 resin microsphere embolization for neuroendocrine liver metastases: a tumor-specific analysis with dose estimation using SPECT …
O Chansanti, Y Jahangiri, Y Matsui, A Adachi… - Journal of Vascular and …, 2017 - Elsevier
Purpose To evaluate dose-response relationship in yttrium-90 (90 Y) resin microsphere
radioembolization for neuroendocrine tumor (NET) liver metastases using a tumor-specific …
radioembolization for neuroendocrine tumor (NET) liver metastases using a tumor-specific …
Transarterial radioembolization for hepatocellular carcinoma: a review
R Sacco, C Conte, E Tumino, G Parisi… - Journal of …, 2016 - Taylor & Francis
Hepatocellular carcinoma (HCC) is the most common type of liver cancer and is the second
cause of death due to malignancy in the world. The treatment of HCC is complex and …
cause of death due to malignancy in the world. The treatment of HCC is complex and …
Multi-modal image analysis for semi-automatic segmentation of the total liver and liver arterial perfusion territories for radioembolization
E Jafargholi Rangraz, W Coudyzer, G Maleux, K Baete… - EJNMMI research, 2019 - Springer
Purpose We have developed a multi-modal imaging approach for SIRT, combining 99m Tc-
MAA SPECT/CT and/or 90 Y PET, 18 F-FDG PET/CT, and contrast-enhanced CBCT for …
MAA SPECT/CT and/or 90 Y PET, 18 F-FDG PET/CT, and contrast-enhanced CBCT for …
Volumetric analysis of pelvic hematomas after blunt trauma using semi-automated seeded region growing segmentation: a method validation study
D Dreizin, UK Bodanapally, N Neerchal, N Tirada… - Abdominal …, 2016 - Springer
Objective Manually segmented traumatic pelvic hematoma volumes are strongly predictive
of active bleeding at conventional angiography, but the method is time intensive, limiting its …
of active bleeding at conventional angiography, but the method is time intensive, limiting its …
Radiologic criteria of response to systemic treatments for hepatocellular carcinoma
Sorafenib has been the only approved systemic therapy for hepatocellular carcinoma until
very recently. However, the radiologic assessment of its biological activity is a disputed …
very recently. However, the radiologic assessment of its biological activity is a disputed …
Semi-automated volumetric quantification of tumor necrosis in soft tissue sarcoma using contrast-enhanced MRI
Background: Response Evaluation Criteria in Solid Tumors (RECIST)-defined
measurements are limited when evaluating soft tissue sarcoma (STS) response to therapy …
measurements are limited when evaluating soft tissue sarcoma (STS) response to therapy …